Cml therapy

Details Cml therapy Cml therapy

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/7068 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2303765

Methods for treating treatment-naive as well as treatment-experienced patients havingCML to achieve at least a partial cytogenetic response involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g., pegylated interferon alfa-2b as monotherapy or in association with a therapeutically effective amount of Ara-C are disclosed.

Affiliated with

Also associated with

Rating

Cml therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cml therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cml therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1629020